The stock's fall snapped a three-day winning streak.

Shares of ResMed Inc. RMD rose 1.67% to $254.70 Monday, on what proved to be an all-around mixed trading session for the ...

Find insight on Johnson & Johnson, Novo Nordisk and more in the latest Market Talks covering Health Care.

UBS analyst Laura Sutcliffe maintained a Hold rating on Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh (RMD – Research ...

Jarden analyst Steven Wheen maintained a Buy rating on Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh (RMD – Research ...

ResMed (NYSE:RMD – Get Free Report) is projected to issue its quarterly earnings data after the market closes on Thursday, ...

For beginners, it can seem like a good idea (and an exciting prospect) to buy a company that tells a good story ...

ResMed’s stock has surged but faces potential risks from GLP-1 drugs. Find out why RMD stock remains a Hold as investors ...

ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks and accessories for the treatment of sleep apnea. Increasing ...

ResMed Trading Up 0.6 % Shares of NYSE:RMD opened at $250.32 on Friday. ResMed Inc. has a 12-month low of $170.56 and a 12-month high of $260.49. The company has a quick ratio of 1.91, a current ...